Randomized study of the OF Bioavailability of different formulations of coenzyme Q10 (Ubiquinone)

被引：17
|
作者：
Constantinescu, Radu
McDermott, Michael R.
DiCenzo, Robert
de Blieck, Elisabeth A.
Hyson, H. Christopher
Beal, M. Flint
Bednarczyk, Edward M.
Bogdanov, Mikhail
Metakis, Linda J.
Browne, Susan E.
Lorenzo, Beverly J.
Ravina, Bernard
Kieburtz, Karl
机构：
[1] Univ Rochester, Med Ctr, Clin Trials Coordinat Ctr, Dept Neurol, Rochester, NY 14620 USA
[2] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA
[3] SUNY Buffalo, Dept Pharm Practice, Buffalo, NY 14260 USA
[4] Hlth Sci Ctr, London, ON, Canada
[5] Cornell Univ, Weill Med Coll, New York, NY USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2007年 / 47卷 / 12期
关键词：
coenzyme Q(10); bioavailability; oral formulations; bioequivalence;
D O I：
10.1177/0091270007307571
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：1580 / 1586
页数：7
相关论文
共 50 条
  • [41] A RANDOMIZED TRIAL OF COENZYME Q10 IN MITOCHONDRIAL DISORDERS
    Glover, Elisa I.
    Martin, Joan
    Maher, Amy
    Thornhill, Rebecca E.
    Moran, Gerald R.
    Tarnopolsky, Mark A.
    MUSCLE & NERVE, 2010, 42 (05) : 739 - 748
  • [42] Bioavailability of Reduced Coenzyme Q10 (Ubiquinol-10) in Burn Patients
    Kuriyama, Naohide
    Nakamura, Tomoyuki
    Nakazawa, Harumasa
    Wen, Tyler
    Berra, Lorenzo
    Bittner, Edward A.
    Goverman, Jeremy
    Kaneki, Masao
    METABOLITES, 2022, 12 (07)
  • [43] Ubiquinone (coenzyme Q10) and mitochondria in oxidative stress of Parkinson's disease
    Ebadi, M
    Govitrapong, P
    Sharma, S
    Muralikrishnan, D
    Shavali, S
    Pellett, L
    Schafer, R
    Albano, C
    Eken, J
    BIOLOGICAL SIGNALS AND RECEPTORS, 2001, 10 (3-4): : 224 - 253
  • [44] RELATIVE BIOAVALABILITY OF COENZYME Q10 FORMULATIONS FOR PEDIATRIC INDIVIDUALIZED THERAPY: PRELIMINARY STUDY
    Martinefski, M.
    Samassa, P.
    Contin, M.
    Lucangioli, S.
    Buontempo, F.
    Tripodi, V.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 50 : E154 - E155
  • [45] Effect of polyethyleneglycol on coenzyme Q10 bioavailability from nanosystems in vitro
    Karlina, M. V.
    Kosman, V. M.
    Pozharitskaya, O. N.
    Shikov, A. N.
    Makarov, V. G.
    Heinamaki, J.
    Yliruusi, J.
    Hiltunen, R.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2012, 46 (04) : 241 - 244
  • [46] Relative bioavailability and antioxidant potential of two coenzyme Q10 preparations
    Kurowska, EM
    Dresser, G
    Deutsch, L
    Bassoo, E
    Freeman, DJ
    ANNALS OF NUTRITION AND METABOLISM, 2003, 47 (01) : 16 - 21
  • [47] Effect of polyethyleneglycol on coenzyme Q10 bioavailability from nanosystems in vitro
    M. V. Karlina
    V. M. Kosman
    O. N. Pozharitskaya
    A. N. Shikov
    V. G. Makarov
    J. Heinämäki
    J. Yliruusi
    R. Hiltunen
    Pharmaceutical Chemistry Journal, 2012, 46 : 241 - 244
  • [48] Relative bioavailability of coenzyme Q10 formulation for paediatric individualized therapy
    Martinefski, Manuela
    Samassa, Paula
    Buontempo, Fabian
    Hocht, Christian
    Lucangioli, Silvia
    Tripodi, Valeria
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2017, 69 (05) : 567 - 573
  • [49] Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization
    Lopez-Lluch, Guillermo
    del Pozo-Cruz, Jesus
    Sanchez-Cuesta, Ana
    Cortes-Rodriguez, Ana Belen
    Navas, Placido
    NUTRITION, 2019, 57 : 133 - 140
  • [50] Bioavailability of Coenzyme Q10: An Overview of the Absorption Process and Subsequent Metabolism
    Mantle, David
    Dybring, Alex
    ANTIOXIDANTS, 2020, 9 (05)
12345